hysterectomy News
-
Memic Performs First Israel Case in Transvaginal Hysterectomy Study
Memic has successfully completed the first case in its Israeli study of transvaginal hysterectomy using the company’s innovative hominis® robotic-assisted surgical platform. The procedure was performed by Prof. Lior Lowenstein of Haifa’s Rambam Healthcare Campus. According to Prof. Lowenstein, “This innovative surgical procedure should replace most of the gynecological ...
-
Hominis Used in First Transvaginal Robotic Hysterectomy in Belgium
In a first-of-its-kind procedure in Belgium, Dr. Jan Baekelandt of Bonheiden’s Imelda Hospital has performed a transvaginal robotic-assisted hysterectomy using Memic’s Hominis® technology. Dr. Baekelandt is a pioneering expert in gynecological oncology, and endoscopic and robotic surgery. His research focuses on transvaginal natural orifice transluminal endoscopic surgery ...
-
Memic Receives FDA De Novo Marketing Authorization for First-Ever Surgical Robotic System with Humanoid-shaped Robotic Arms
Memic, a medical device company dedicated to transforming robot-assisted surgery with its proprietary technology, today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo marketing authorization of its Hominis® robot-assisted surgical platform for use in single site, natural orifice laparoscopic-assisted transvaginal benign surgical procedures including benign ...
-
US FDA awards Breakthrough Device Designation to Australian labour monitoring device, Oli
BaymatobTM, a MedTech company founded by a Sydney mother after her own traumatic birth experience, has developed a world-first labour monitoring device that has achieved US Food and Drug Administration (FDA) Breakthrough Device Designation. This sets Baymatob’s game changing maternal diagnostic tool called OliTM on an streamlined and supported path toward regulatory approval. Oli seeks to ...
-
Merck Announces Acquisition of Alydia Health on behalf of its Planned Spinoff of Organon
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Alydia Health announced today that they have entered into a definitive agreement pursuant to which, after the intended Merck spinoff of Organon, Organon will acquire Alydia Health. Alydia Health is a commercial-stage medical device company focused on preventing maternal morbidity and mortality caused by postpartum ...
-
Memic Innovative Surgery to Demonstrate Use of Hominis® Surgical System at AAGL 2021
Company to showcase first and only FDA-authorized surgical robot that features miniature humanoid-shaped arms and host in-booth surgeons to discuss their experiences with Hominis Tel Aviv, Israel and Fort Lauderdale, FL, November 11, 2021 – Memic Innovative Surgery (Memic), a medical device company dedicated to transforming healthcare with its proprietary surgical robotic technology, ...
-
Versius adopted by Cristo Re Hospital to increase patient access to keyhole surgery in Rome
CMR Surgical – the global medical device company headquartered in Cambridge, UK – has announced the installation of its first Versius system in Rome, at the Cristo Re Hospital. Cristo Re is part of the renowned GIOMI Group and is the first of the leading group of private clinics in Italy to install this practical and innovative surgical tool. Versius is being used as part of a ...
-
Gynesonics Announces Positive Payer Coverage Issued by Blue Cross Blue Shield of Florida (Florida Blue) for the Sonata Treatment
Redwood City, CA, June 11, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today Blue Cross Blue Shield of Florida (Florida Blue) has released a coverage policy for its Sonata® Procedure.1 The addition of the Florida Blue policy allows another 5 million covered lives in ...
By Gynesonics
-
Gynesonics Announces Anthem, the Second Largest Healthcare Payer in the U.S., Issues Medical Necessity Coverage for the Treatment of Symptomatic Uterine Fibroids with the Sonata Procedure
Redwood City, CA, September 14, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced Anthem, Inc., the largest managed health care company in the Blue Cross Blue Shield Association, has provided positive payer coverage for the Sonata® Treatment. Anthem’s decision creates ...
By Gynesonics
-
Gynesonics Announces Expert Group of European Gynecologic Surgeons Publishes Consensus on the Broad Use of the Sonata Technology in a New Treatment Strategy for Symptomatic Fibroids
Redwood City, CA, August 11, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today a group of 12 surgeons from multiple fibroid treatment centers in Germany, Austria and Switzerland have published a review of symptomatic fibroid treatments, and recommended a treatment algorithm ...
By Gynesonics
-
University Hospital Tübingen carries out first Dexter surgeries in Germany
On-demand robotics is a new technique for laparoscopic surgery. It has been used in Germany for the first time by the Department for Women’s Health and Gynecology at the University Hospital Tübingen. Together with the University Hospital Tübingen we announced today the successful completion of gynecological surgeries using Dexter®. This marks Dexter’s first clinical ...
-
Gynesonics Announces First Office-Based Sonata Procedure in the State of Texas
Redwood City, CA, October 5, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that Dr. John Thoppil is the first physician in the state of Texas to offer its Sonata® Treatment to women with symptomatic uterine fibroids as an office-based procedure at his River Place ...
By Gynesonics
-
Gynesonics Announces Positive Coverage Policy Decision Published by Cigna for Treatment of Uterine Fibroids with the Sonata System
Redwood City, CA, June 3, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that Cigna has released a national coverage policy for treatment of uterine fibroids with the Sonata® System.1 Cigna is one of the largest commercial payers in the country with a significant ...
By Gynesonics
-
Gynesonics Announces FDA Clearance of Next Generation Sonata System
Redwood City, CA, September 16, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today the Food and Drug Administration (FDA) has given clearance of the Sonata® System 2.2 which provides important new benefits for facilities, physicians and patients. These benefits include: ...
By Gynesonics
-
Sydney MedTech Baymatob completes capital raise to advance life-saving labour monitoring device
Sydney medical device company Baymatob has completed a placement of $4.215 million, with proceeds used to continue in-human clinical trials for its AI-guided labour monitoring device, Oli. Cornerstoned by Australian Unity’s Future of Healthcare Fund, the placement was strongly supported by Australian institutional and high net worth investors, securing long-term capital partners to support ...
-
New US research finds deadly links betweem talcum powder and ovarian cancer
What could be more benign than body powder, right? Some of Chicago's most highly placed doctors would say, wrong. They are part of a coaltion of public health experts, medical doctors and consumers organizations that is petitioning the federal goverment for warning labels on cosmetic talcum powder products used by many women as part of their personal care regime - a warning that frequent use is ...
-
Memic Announces Robert L. Ryan and Sandra Morgan to Join Board of Directors Upon Closing of Business Combination with MedTech Acquisition Corporation
Tel Aviv, Israel and Fort Lauderdale, FL, September 9, 2021 – Memic Innovative Surgery Ltd. (the “Company” or “Memic”), a medical device company dedicated to transforming surgery with its proprietary surgical robotic technology, today announced that Robert L. Ryan and Sandra Morgan have agreed to join the company’s board of directors. Ryan and Morgan, who ...
-
Asensus Surgical Provides Preliminary 2021 Year-End Corporate Update
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today provided a preliminary 2021 year-end corporate update. Fourth Quarter Highlights Over 500 procedures were performed globally during the quarter, representing growth of over 25% over the ...
-
Memic Announces Adoption of Hominis® Surgical System at Three Leading U.S. Hospitals in Q4 2021
HCA Florida Healthcare’s Kendall Regional Medical Center, AdventHealth Celebration and The Women’s Hospital at Jackson Memorial now offer first-ever surgical robot with humanoid-shaped arms for use in transvaginal gynecological procedures Previously announced proposed business combination with MedTech Acquisition Corporation (Nasdaq: MTAC) anticipated to close in first quarter of ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you